Introduction
Nonviral vectors for gene therapy enter cells by endocytosis and traffic via endosomes before being released into the cytoplasm for nuclear transfer. 1 One of the major barriers to efficient gene transfer is the nuclear envelope that selectively controls passage of macromolecules from the cytoplasm to the nucleus. Nuclear transport of oligonucleotides and plasmid DNA (pDNA) has been studied following: (1) transfection of whole cells; [1] [2] [3] [4] [5] (2) microinjection into the cytoplasm; [6] [7] [8] [9] [10] [11] [12] [13] and (3) transfection of plasma membrane-permeabilised cells, 12, [14] [15] [16] [17] with the aim of determining the mechanism of transfer. Although the nuclear transport of pDNA is less well understood than nuclear protein transport a number of these studies 5, 7, 13, 18 suggest that transfer occurs via the nuclear pore complex (NPC) similar to protein import and export. The NPC, a multiprotein complex, allows for active, energy-dependent, or passive transport of macromolecules (for review,
energy-dependent process involving the nuclear pore complex, since it is inhibited at 4°C and by treatment with wheat germ agglutinin or with an antibody to the nuclear pore complex which all block nuclear protein import. In accordance with active nuclear transport, we have shown that all these treatments inhibit expression of a luciferase reporter plasmid in permeabilised cells. Nuclear transfer of pDNA is enhanced in mitotic cells, but cell division is not a prerequisite for transfer. We propose that the oligolysine-RGD peptide acts as a nuclear localisation signal and that the cationic lipid is more important for cell entry and endosome destabilisation than nuclear transfer. Gene Therapy (2001) 8,

1643-1653.
see Refs 19 and 20) . Active protein transport requires interaction of specific nuclear localisation signal (NLS) sequences on proteins with importins, that in turn interact with the protein RanGDP and carry cargo into the nucleus. These amino acid sequences characteristically bare a strong positive charge. An enhancement of nuclear transfer and/or expression of pDNA in the presence of a NLS, either covalently 5, 10, 12, 21 or noncovalently 2, 3, 6, 16, [22] [23] [24] [25] [26] associated with the pDNA was found, which together with the observed interaction of NLS-pDNA constructs with the α-importin NLS nuclear import receptor 3, 21 supports the hypothesis of an involvement of the NPC machinery in the nuclear transfer of pDNA. However, it has also been observed that transfection is optimal in actively proliferating cells and thus it has been suggested that exogenous pDNA enters the nucleus during mitosis when breakdown of the nuclear envelope occurs. [27] [28] [29] [30] The majority of studies into nuclear transport of pDNA have been performed with either naked pDNA or a NLSpDNA, while only a few studies have examined the mechanism of transfer of pDNA in the presence of a cationic polymer or liposome. 11, 31 Yet the latter methodology is the most widely used for in vitro transfection.
We and others have previously demonstrated the prin-ciple of integrin-mediated gene transfer using a bifunctional oligolysine-RGD peptide which condenses pDNA and binds to RGD-recognising integrins on the cell surface. [32] [33] [34] [35] In addition, we have demonstrated that the presence of a liposome enhances substantially the level of gene expression of this construct. 1, 32, 36 It was, however, not clear whether this enhancement is entirely due to the targeting function of the oligo-peptide or if it may also be able to confer a nuclear targeting function by virtue of its strong positive charge. In this study, we set out to investigate the nuclear transport of the pDNA when complexed to an oligolysine-RGD peptide and/or liposome and to examine the role of the NPC in this transfer. We chose to use digitonin-permeabilised cells to examine nuclear transport since this cell system has proven to be invaluable in understanding nuclear protein import and export. 37 The detergent digitonin selectively permeabilises membranes rich in cholesterol, such as the plasma membrane, while leaving intact the membranes of intracellular organelles with low levels of cholesterol, such as the nucleus 37 and secretory granules. 38 This system thereby allows direct access of various agents to the nucleus for the study of nuclear transfer and unlike microinjection a large population of cells can be examined. In addition, we have examined the role of the cell cycle in nuclear transfer with the aim of determining whether dismantling of the nuclear envelope during mitosis makes pDNA transfer more efficient.
The results presented here indicate that both the oligolysine-RGD and -RGE peptides are able to mediate nuclear transfer of pDNA much more efficiently than oligolysine on its own, indicating that the charge is not the main factor involved in this function. We also found that the liposome lipofectamine promotes nuclear transfer in digitonin-permeabilised cells, but not in cells microinjected with the complex. Despite permeabilisation, lipofectamine may enhance cell entry and thus increase the amount of pDNA that comes in contact with the nucleus. In digitonin-permeabilised cells oligolysine-RGD and -RGE act synergistically with lipofectamine to enhance nuclear transfer of pDNA. In addition, the mechanism of [K] 16 RGD/RGE nuclear transfer of pDNA appears to involve the nuclear pore complex machinery. Furthermore, this study also indicates that although nuclear transfer is more efficient in cells undergoing mitosis, substantial nuclear translocation also occurs in nondividing cells.
Results
The oligolysine-RGD peptide enhances transfer of pDNA to the nucleus To examine nuclear transport of pDNA we adopted the well-established digitonin-permeabilised cell system which has been extensively used in the study of the nuclear transport of proteins. 37, 39 To verify that the nuclear membrane of the human tracheal cells used in this study remains intact during permeabilisation with digitonin the nuclei of permeabilised cells were tested for their capacity to exclude FITC-labelled dextran of 70 kDa ( Figure 1 ). No FITC label (green) could be detected by confocal microscopy in nuclei counterstained with the DNA binding dye propidium iodide (red), thus indicating that the nuclear membrane remains intact. This was 16 peptide also transferred to the nucleus, but the label appeared to be less intense ( Figure  2c ). To test if the oxidised/reduced state of the peptide affected nuclear transfer FITC-labelled oxidised (cyclic) or reduced (non-cyclic) peptides were examined for nuclear transfer (Figure 3 ). However, both peptides appeared to enter the nucleus within 30 min. When Cy5-labelled pDNA (pseudo-blue) alone was added to digitonin-permeabilised cells, no label was detected in nuclei counterstained with propidium iodide (red) (Figure 4a ). When the Cy5-pDNA was condensed with the [K] 16 RGD peptide, only a low level of label was seen in nuclei ( Figure 4b ). When lipofectamine was complexed with Cy5-pDNA label was observed in the nuclei (Figure 4c ) and addition of lipofectamine to the Cy5-pDNA: [K] 16 RGD complex clearly enhanced the amount of pDNA in the nucleus (Figure 4d ). Under these conditions colocalisation of Cy5-pDNA and FITC-[K] 16 RGD was observed in the nucleus as shown by the white signal resulting from the merger of red, blue and green ( Figure  5a 16 16 RGE peptides does not enter the nucleus in a detectable amount, 1 we suggest that the mechanism by which it enhances nuclear transfer on its own is different from that of the two peptides.
The overall luciferase expression levels were higher in digitonin-permeabilised compared with non-permeabilised cells ( Figure 6 ). This appears to be primarily due to an increase in the amount of pDNA, that enters cells and thus comes in contact with the nucleus irrespective of its complexing with a peptide. However, importantly the mean expression levels in permeabilised cells for the [ 16 alone again suggesting that the RGD and RGE motifs enhance nuclear transfer.
When the pDNA:[K] 16 RGD complex was microinjected into the cytoplasm of cells, no label was observed in the nucleus at the control zero time (T0) but label was seen in the nucleus after 2 h (T 2h), whether or not the complex was prepared with lipofectamine ( Figure 7 ). The label appeared to remain in a compact form within the nucleus. However, not all nuclei of microinjected cells took up the label (data not shown). No label was observed in the nuclei of cells microinjected with Cy5-labelled pDNA alone. These results suggest that the peptide is the major determining factor in nuclear transfer, but they appear to be in conflict with the data presented in Figure 4 , which suggest that lipofectamine favours nuclear transfer. It may be that in digitonin-permeabilised cells lipofectamine enhances cell entry and protection of the pDNA and thus brings increased amounts in contact with the nucleus. It is, however, hazardous to draw quantitative conclusions from confocal images. It should also be noted that due to the small amount of sample injected into the cytoplasm of cells (about 1 pl) the amount of complex that comes in contact with the nucleus is potentially lower in microinjected cells than in permeabilised cells and the complex is presented in a microdrop form rather than as a diffuse solution enrob- ing the nucleus. In conclusion, we suggest that lipofectamine is more important for cell entry and protection of the pDNA, and possibly destabilisation of endosomes, than for nuclear transfer.
Nuclear transfer of complexed pDNA involves the nuclear pore complex Nuclear transfer of NLS-containing proteins is inhibited at 4°C, 37 and is blocked by agents which bind the nuclear pore complex such as the lectin wheat germ agglutinin (WGA), 37, 39 or specific antibodies to a nuclear pore complex protein. 40 To determine if nuclear transfer of oligolysine-RGD:lipofectamine complexed Cy5-pDNA was also inhibited by such treatments permeabilised cells were either maintained at 37°C (control) (Figure 8a ) or at 4°C (Figure 8b ) or they were pretreated with either WGA observed in the nucleus when cells were treated with an antibody to the nuclear pore complex (yellow) ( Figure  8d ). Since quantification of the fluorescence of confocal images is not very reliable, we attempted to confirm and quantify this inhibition by determining the luciferase activity expressed in digitonin-permeabilised cells. We hypothesised that since the protein luciferase localises to peroxisomes, 41 it may not leak from permeabilised cells as do small macromolecules like ATP and cytoplasmic proteins such as lactate dehydrogenase (LDH) and thus synthesis of luciferase and detection of its activity could be possible. Permeabilised cells transfected at 4°C showed significantly reduced luciferase expression levels compared with 37°C (Figure 9a ). Incubation of non-permeabilised control cells in the presence of WGA or an antibody to the nuclear pore complex resulted in a slight decrease in the level of expression (Figure 9b ). However, permeabilisation also allows entry of the inhibitors into the cell and incubation of permeabilised cells in the presence of WGA or an antibody to the nuclear pore complex resulted in an approximate five-fold and three-fold decrease in the level of expression, respectively, compared with non-permeabilised treated cells. To verify that digitonin treatment did indeed result in permeabilisation of cells the release of ATP and LDH at different digitonin concentrations was determined. Digitonin at the concentration of 20 g/ml resulted in the release of a substantial amount of ATP ( Figure 9c ) and LDH (Figure 9d ) into the extracellular medium. Release of LDH at high digitonin concentrations did not reach 100% probably due to the presence in cells of LDH in subcellular compartments, such as mitochondria. 42 In addition, de novo protein synthesis is already detected 2 h after permeabilisation, although at a reduced level as determined by incorporation of [ 1.5, respectively. This result and the measurements of luciferase expression suggest that digitonin momentarily forms pores in the plasma membrane allowing for entry of different agents, but that the cells recommence protein synthesis which reaches a normal level 48 h after the transfection period when the luciferase activity is determined. To further confirm the presence of the luciferase protein in permeabilised cells, fluorescence immunodetection of the protein was performed (Figure 9f ). Microscopic examination showed the presence of the luciferase protein in vesicles that were predominantly perinuclear. In addition, the luciferase protein was detected in the large majority of cells thus indicating that the detected luciferase activity was not due to just a few highly expressing cells that had not been permeabilised.
Optimal expression in mitotic cells
To examine the role played by the cell cycle in nuclear transfer, cells were incubated in the presence of either demecolcine, which blocks cells in the G2/M phase, or hydroxyurea, which blocks cells in the G0/G1 phase. FACS analysis was used to determine the percentage of cells in the respective cycle phases. In the presence of demecolcine about 60% of the cells were in the G2/M phase (Figure 10a, left) and in the presence of hydroxyurea about 60% of the cells were in the G0/G1 phase (Figure 10a, right) . In fact, half the control cells at 80% confluence were already in the G0/G1 phase. Treated cells were transfected in the presence of the respective drug that was then removed and the luciferase activity was determined after the 48-h post-transfection period. Cells in the G2/M phase showed an approximate four- fold increase in the luciferase expression level compared with non-synchronised control cells (Figure 10b, left) , while cells in the G0/G1 phase showed a lower but nonetheless considerable level of expression similar to those of a non-synchronised control (Figure 10b, right) . Confocal microscopy analysis showed the presence of labelled pDNA in the nuclei of cells treated either with demecolcine (Figure 10c , left) or hydroxyurea (Figure 10c , right) when transfected with the Cy5pDNA:[K] 16 RGD: lipofectamine complex. These results suggest that the dismantling of the nuclear membrane during mitosis favours nuclear transfer, but that transfer also occurs when the nuclear envelope is intact and that mitosis plays a relatively limited role in the entry of the [K] 16 RGD/E pDNA complexes into the nucleus.
We tested the possibility that an increase in expression observed in cells in mitosis was due to an increase in the Since the cell-associated radioactivity for demecolcine-treated cells was lower than for either control or hydroxyurea-treated cells, we conclude that the increase in expression levels in mitotic cells was due to an increase in the nuclear transfer and not cell uptake ( Figure 11 ). It should be pointed out that cell-associated radioactivity includes internalised complex, but also complex that may remain bound to the cell surface.
Discussion
Inspired by the knowledge that protein transport into the nucleus requires specific amino acid sequences referred to as nuclear localisation signals (NLS), several attempts to enhance nuclear transfer of plasmid DNA (pDNA) by covalent 5, 10, 12, 21 or non-covalent association 2,3,6,16,22-26 of pDNA with an NLS have been reported. The most frequently employed NLS is the classic monopartite sequence of the large T antigen of SV40 that is composed of a single stretch of basic amino acids; lysine and argiGene Therapy Figure 11 The 
nine. Sebestyén et al
12 covalently attached this NLS to pDNA (up to 11 kb) and observed nuclear transfer of the pDNA in digitonin-permeabilised cells when the pDNA was conjugated with a high ratio of NLS peptide. Transfer was inhibited at 4°C and in the presence of wheat germ agglutinin (WGA) which is known to inhibit NLSprotein import through the nuclear pore complex, thus suggesting that nuclear transfer involves an energydependent active transport through the nuclear pore. The finding that NLS-pDNA constructs can interact with α-importin, an NLS nuclear import receptor 3,21 supports this hypothesis. However, no nuclear transfer of this and another NLS-DNA conjugate could be observed after their microinjection into the cytoplasm of cells, possibly as a result of cytoplasmic sequestration. 12, 21 Yet, other covalent NLS-pDNA constructs have been shown to be present in nuclear fractions of zebrafish embryos after microinjection into the cytoplasm, 6 and to result in an increase in expression levels in cells transfected in the presence of either a cationic lipid or polymer. 5, 21 Non-covalent association of an NLS with the pDNA has also been reported to enhance expression levels in cells. 3, 6, 16, 22, 25, 43 In addition, using a bifunctional peptide nucleic acid (PNA)-NLS, where PNA forms duplex hybrids with complementary DNA, Brandén et al 2 demonstrated increased association of pDNA with the nucleus and expression in cells transfected in the presence of polyethylenimine (PEI). Thus the results concerning covalent and non-covalent association suggest that NLS binding to DNA and subsequent enhancement does not require a cross-linking agent and covalent binding may even be detrimental in abolishing transcription, in particular when many NLS molecules are present per pDNA. 12 To determine whether the previously observed increase in expression and the increase in the amount of pDNA in isolated nuclear fractions in the presence of peptide and/or liposome 1,33 is due in part to an increase in the transfer of the pDNA to the nucleus, we examined the nuclear transfer of the pDNA in digitonin-permeabilised cells with or without the oligolysine-RGD peptide 16 , in the presence of an excess amount of liposome also suggested to us that the peptides may be acting as an NLS and thereby enhancing nuclear transfer. Increased expression in digitonin-permeabilised cells in the presence of the RGD/RGE peptides further supports this hypothesis. Examination of the peptide sequences on the protein data base PSORT II predict their nuclear localisation and suggest that they are bipartite NLS-like basic peptides.
The mechanism by which [K] 16 RGD/E peptides permits nuclear transfer of pDNA appears to involve the nuclear pore and to be an active process, since transport is inhibited at 4°C and under conditions that block transport through the nuclear pore complex. Thus these results suggest that the peptide acts as an NLS and that the bipartite nature of the [K] 16 RGD peptide, ie the [K] 16 motif and the arginine residue are necessary since the [K] 16 peptide appears to have a lower affinity for the nucleus and does not enhance expression levels. Chan and Jans 3 also found that polylysine in contrast to a polylysine/NLS conjugate does not increase nuclear import. Godbey et al 31 showed that the polycation PEI which enhances gene expression undergoes nuclear localisation when added to cells with or without pDNA and Pollard et al 11 showed that this polymer and polylysine promoted gene delivery from the cytoplasm to the nucleus in microinjected cells. An alternative explanation for the peptide-induced transfer observed in this study may be that the substantial amount of [K] 16 RGD/E peptides in the nucleus modifies the characteristics of the nucleus which in turn favours nuclear penetration of the pDNA.
The mechanism by which the liposome lipofectamine enhances nuclear transfer in this study is yet to be defined. It is possible that the hydrophobic and/or cationic characteristics of lipofectamine favour interaction with the nuclear membrane and/or that the condensation of the pDNA by a cation reduces its size and thus facilitates passage into the nucleus. It has been shown however that pDNA complexed to the cationic lipids when microinjected into the cell cytoplasm did not result in an increase in gene expression possibly as a result of cytoplasmic sequestration. 11, 44 A recent report demonstrated that lactosylated poly-l-lysine resulted in nuclear translocation of pDNA by a NPC-dependent mechanism, but that unsubstituted poly-l-lysine or mannosylated poly-llysine were less efficient for transfer. 45 The authors postulate that the lactose moiety provides for nuclear localisation by targeting a potential lectin-like protein of the NPC.
The nuclear pore complex acts as a gateway between the cytoplasm and the nucleus and is a multiprotein structure which forms a large central transporter channel (50-60 nm in diameter) surrounded by eight peripheral diffusion channels (approximately 10 nm in diameter). 20 Diffusion of macromolecules appears to be limited to a size of approximately 50 kDa, thus peptides of about 3 kDa such as [K] 16 RGD can theoretically diffuse into the nucleus. However, the size of the [K] 16 RGD:pDNA complex, estimated to possess a diameter of about 20-100 nm, 33 would exclude transport by diffusion. The addition of lipofectamine, estimated to have a mean diameter of about 90 nm 46 would also increase the overall size, though it is possible that this component of the complex does not enter the nucleus. Our previous studies into the localisation of lipofectamine by electron microscopy in the cell did not reveal its presence in the nucleus. 1 Thus the sizes of these components suggest that transfer occurs via the central energy-dependent channel unless the pDNA is capable of threading through the NPC in a worm-like manner as previously suggested. 5 We were also interested in examining the relationship between the cell cycle and nuclear transfer since breakdown of the nuclear membrane during mitosis may open the way to nuclear transfer. Several studies have demonstrated that cells arrested in the G1 phase show reduced gene expression after transfection with either a cationic lipid or polycation, 8, 13, 29 while cells in mitosis show increased expression. 27, 30 Nonetheless significant gene expression was observed in non-dividing cells 8 and cell division was not required for expression of a pDNA complex to PEI when injected into the cell cytoplasm. 5 Studies by Brunner et al 27 and Escriou et al 47 showed substantial increases in expression (30-500-fold) for mitotic cells compared with cells in the G1 phase when transfected with a cationic lipid or polymer. However, when an adenoviral system was used no substantial enhancement in expression (four-fold) was observed in mitotic cells. This suggests that when an efficient nuclear entry machinery is present as in the case of the adenovirus, the breakdown of the nuclear membrane does not influence the level of transfer. 27 Our studies confirm the findings obtained with nonviral systems and suggest that the dismantling of the nuclear envelope favours nuclear transfer, but is not a prerequiste for transfer in particular if an efficient NLS-like mechanism which employs the nuclear entry machinery is present.
In conclusion, results presented here indicate that: (1) the peptide [K] 16 RGD/RGE enhances nuclear transfer of pDNA, probably as a result of its bipartite NLS-like sequence and interaction with the NPC; (2) the liposome lipofectamine is probably more important for cell entry and possibly endosome escape than nuclear translocation; and (3) cells in mitosis possess enhanced nuclear transfer, but cell division is not a prerequisite for nuclear transfer.
Materials and methods
Cell culture
The fetal human tracheal epithelial cell line 56FHTE8o-was kindly provided by Dr D Gruenert. 48 Cells were grown in a 1:1 mixture of Dulbecco's minimum essential medium and Ham's F-12 nutrient medium (DMEM/F-12) and supplemented with foetal calf serum (10% v/v) (Biowest, Nuaillé, France). Cells were maintained at 37°C in 5% CO 2 -95% air and the media changed every second day. Cells were seeded on either six-or 12-well plates, 16 RGE peptides were labelled with FITC as previously described. 32 An American firefly (Photinus pyralis) luciferase pDNA (5256 bp) (pGL3) under the control of an SV40 promoter and enhancer was used as a reporter gene. pDNA was purified and labelled with Cy5 by a modified nick-translation technique giving predominantly an open circle form as previously described. 32, 49 The pDNA (1 g) was labelled in the presence of 10 -6 units of DNase I and the integrity of the pDNA confirmed by electrophoresis on an agarose (0.8%) gel and staining with ethidium bromide (data not shown). The Cy5-label was detected using a Molecular Dynamics fluorescence scanning system (Storm 860) with excitation at 649 and emission at 670 nm (data not shown). 16 RGE peptides (FITC labelled or nonlabelled) were mixed with the pDNA at a ratio of five to one (w:w), respectively, and incubated 15 min at room temperature in HEPES buffered saline. Peptide at this ratio condenses the DNA as shown by electron microscopy and renders it resistant to Dnase. 33 Lipofectamine (2 mg/ml) at 3:1 (w:w) mixture of a polycationic lipid (DOSPA) and a neutral lipid (DOPE), was then added (final ratio DNA:peptide:lipofectamine; 1:5:18 or 1:5:24 (w:w:w) and the mixture incubated a further 15 min at room temperature.
Complex formation
The [K] 16 RGD, [K]
Cell synchronisation
Cells were synchronised in the G2/M phase by pretreatment with demecolcine (0.06 g/ml), for 16 h at 37°C or in the G0/G1 phase with hydroxyurea (2.5 mm) for 18 h at 37°C. Cells were then harvested in trypsin (0.05%)/EDTA (0.02%) and fixed in cold 70% ethanol overnight. After washing with PBS, cells were resuspended in PBS containing RNase A at 1 mg/ml and propidium iodide at 50 g/ml. After 30 min at room temperature, the red fluorescence of the propidium iodide was detected and analysed on a FACScalibur (Becton Dickinson, Le Pont de Claix, France) equipped with an argon laser emitting at 488 nm.
Transfection and luciferase detection
The complex (pDNA:[K] 16 RGD:lipofectamine, 0.08 g:0.4 g:1.4 g, per well) was added to permeabilised or nonpermeabilised cells in a final volume of 300 l of Opti-MEM (Gibco BRL). Cells were then incubated at 37°C for 4 h after which the complex was removed. The cells were then washed in PBS, the normal supplemented media added and incubated for a further 48-h post-transfection period. Forty-eight hours was found to give optimal luciferase activity (data not shown). Luciferase activity was assayed as previously described 32 and the protein concentration of cell lysates was determined using the Bradford method. 50 For inhibition of nuclear pore transport, permeabilised cells were pretreated with 50 g/ml WGA (Sigma, St-Quentin Fallavier, France) for 30 min at Gene Therapy room temperature before the addition of the complex and subsequent detection of luciferase activity. This lectin binds N-acetylglucosamine residues present on a class of nuclear pore complex (NPC) proteins. In addition, inhibition of nuclear pore transport in permeabilised cells was performed by pretreatment with the Mab 414 antibody which recognizes a related family of NPC proteins (Babco, Berkley, USA) 40 for 30 min at room temperature at a working dilution of 1/10 000. Cells synchronised in the G2/M phase by pretreatment with demecolcine (0.06 g/ml), for 16 h at 37°C or in the G0/G1 phase with hydroxyurea (2.5 mm) for 18 h at 37°C were transfected in the presence of drug as described above and the 48-h post-transfection was performed in the absence of drug. 
ATP and lactate dehydrogenase release
Cell ATP and lactate dehydrogenase (LDH) release was measured after permeabilisation of cells with digitonin (10-150 g/ml). For ATP release,cells were rinsed three times with DMEM/F-12 medium and incubated with ATP degradation inhibitors: P 1 ,P
5
-di (adenosine-5Ј) pentaphosphate (Sigma) and adenosine 5Ј-diphosphate (Sigma) respectively at 0.5 mm and 1 mm in DMEM/F-12 medium, 3 min at 37°C. Cells were then prechilled and permeabilised with digitonin (10-150 g/ml) containing inhibitors, for 5 min on ice (600 l per well). The medium was collected and the ATP measured using an adenosine 5Ј-triphosphate bioluminescence assay kit (Sigma) and detected as relative light units (RLU) emitted. Results are expressed as extracellular ATP. For detection of the lactate dehydrogenase (LDH) activity cells were prechilled and incubated 5 min on ice with the indicated digitonin concentration. After two rinses with PBS, cells were scrapped into 1 ml of PBS and centrifuged for 10 min at 4°C at 800 r.p.m. The pellet was resuspended in hypotonic lysis buffer (500 mm Tris HCl pH 7.4, 100 mm NaCl, 3 mm MgCl 2 , 1 mm EDTA, 1 mm EGTA, 0.5% deoxycholate, 0.1% SDS, Nonidet P40) and the cytoplasmic marker lactate dehydrogenase was assayed with a Synchron CX4 CE (Beckman Gagny, France) analyser using pyruvate and NADH as substrates. Results are expressed as a percentage of the LDH in non-permeabilised cells. Cell viability was determined by the trypan blue exclusion assay and triplicate samples were counted in a haemocytometer. 32 Cells were then incubated with the complex for the indicated times. After rinsing with PBS, cells were harverested with trypsin/EDTA, the trypsin was blocked with of 1% BSA in PBS and cells recovered by centrifugation (10 min, 1100 g). The cell pellet was rinsed once in PBS by centrifugation before lysis in 1 N NaOH. The radioactivity was measured by scintillation counting in a 1600TR analyser (Packard, Rungis, France) and the protein content determined by the method of Bradford. Results are expressed as c.p.m/mg of protein.
Disulphide bridge peptide reduction
To determine the impact on nuclear transport of disulphide bond formation between the cysteine residues of the peptide, a sample of the peptide was reduced with dithiotreitol (DTT). DTT was added in a five-fold excess relative to thiol groups (ie 0.3 mm) to a 1 mg/ml solution of peptide in 0.1 m ammonium bicarbonate pH 8.0 and incubated for 6 h at room temperature in a nitrogen atmosphere. The mixture was then acidified to pH 7.4 with acetic acid. To verify reduction of the disulphide bridge in the peptide an Ellman's assay was performed. Fifty l of 3 mm DNTB (5,5Ј-dithio-bis(2-nitrobenzoicacid) was added to 1 ml of 0.1 mg/ml peptide solution. The absorbance at 412 nm was measured on a spectrophotometer after incubation for 15 min. The concentration of sulphydryl groups was calculated from the molar extinction coefficient of 14150/cm using the follow- To verify the integrity of the nuclear membrane of permeabilised cells, they were incubated with 500 g/ml FITC-dextran (MW 70 000, Sigma) for 30 min at 37°C. Cells synchronised in the G0/G1 or G2/M phase were permeabilised and the nuclear transfer of the Cy5-pDNA:[K] 16 RGD:lipofectamine complex at the optimal ratio of 1:5:18 (w/w/w) for 1 h at 37°C examined. To test the nuclear transfer of cyclised and non-cylised peptide, cells were permeabilised and rinsed twice with PBS and incubated with 0.1 mg/ml of cyclised or non-cyclised [K] 16 RGD, 30 min at 37°C. Control cells pretreated with DTT were incubated a further 30 min at room temperature with 500 g/ml FITC-dextran to determine nuclear membrane integrity. Cells were washed twice in PBS, fixed for 20 min at room temperature in 4% paraformaldehyde (PFA), rinsed in 50 mm NH 4 Cl for 5 min at room temperature. Cells were treated with 1 mg/ml of RNase A 10 min at room temperature and nuclei were then stained with propidium iodide (3 g/ml) for 3 min at room temperature. Cells were then mounted in DABCO/glycergel (Dako, Trappes, France). For detection of the luciferase protein, cells were transfected as described above. After a 48-h post-transfection period, cells were incubated in the presence or absence of digitonin (20 g/ml) for 5 min on ice, washed twice in PBS, fixed for 20 min at room temperature in 4% PFA and rinsed four times in 50 mm NH 4 Cl for 5 min at room temperature. Cells were then incubated with a fluorescein-conjugated IgG anti-luciferase (firefly, Photinus pyralis) antibody (Rockland, Gilbertsville, USA) for 1 h at room temperature at a working dilution of 1/7500 in the presence of 0.% saponin. Cells were then washed four times with 50 mm NH 4 Cl for 5 min at room temperature and treated as described above. Confocal microscopy was performed using a TCS SP Leica (Lasertechnichk) microscope, equipped with a × 40 objective (plan apo; NA = 1.25). For FITC excitation, an argon-krypton ion laser adjusted at 488 nm was used, 568 nm for propidium iodide and 647 nm for Cy5 excitation. For each optical section, triple fluorescence images were obtained in the sequential mode (ie FITC first, TRITC second and Cy5 third). The signal was treated by line averaging to integrate the signal collected over four lines in order to reduce noise. The confocal pinhole was adjusted to allow for a minimum field depth. A focal series was collected for each specimen. The focal step between each section was 0.9 m. Selected sections were then processed to produce a single composite overlay image (colour merged). Images were printed on a colour ink jet printer (Epson Stylus color 850) using Photoshop 5.0 software. 
Statistical analysis
